SC 13G Filing

Company

Theriva Biologics, Inc.

Filed

February 23, 2001

Accession Number

0000919574-01-000306

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →